Influence
June 22, 2021

Regenstrief experts share cancer-related research as part of IU Simon Cancer Center Series

Two Regenstrief research scientists who focus on cancer research are sharing their knowledge in the Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s monthly series called “Simon Says.” 

The monthly virtual series was created to better connect cancer experts with the community, giving people the opportunity to hear about the latest research and ask questions.  

Dr. Clint Cary

Regenstrief Research Scientist K. Clinton Cary, M.D., MPH, is speaking at the June 30, 2021 presentation called “Keeping Our Eyes on the Ball: IU’s Leadership in Testis Cancer Research and Care.” He will be joined by a cancer survivor to discuss treatment options for testicular cancer, with a focus on nerve-sparing surgical techniques that were developed at IU. Dr. Cary is a urological oncologist who also conducts research on improving the health of patients with urologic cancers through health services and outcomes research in testis, bladder and prostate cancer. 

Shelley Johns, PsyD

On July 27, 2021, Regenstrief Research Scientist Shelley Johns, PsyD, will present “Waiting for the Other Shoe to Drop: Coping Effectively with Fear of Cancer Recurrence.” That fear is one of the most prevalent and disruptive problems that cancer survivors face. Dr. Johns works in the clinic with cancer survivors to help them cope with that fear, and she is conducting clinical trials to validate new ways to treat it. In this Simon Says session, she will discuss how her research seeks to support survivors in coping effectively with fear of recurrence.

Sign up for the upcoming sessions here.

Past Simon Says recordings are also available on the site.  

About K. Clinton Cary, M.D., MPH

In addition to his role as a research scientist at Regenstrief Institute, K. Clinton Cary, M.D., MPH, is an associate professor of urology and director of Urologic Oncology Research within the Department of Urology at Indiana University School of Medicine.

About Shelley Johns, PsyD  

In addition to her role as a research scientist at Regenstrief Institute, Shelley A. Johns, PsyD, is a board-certified clinical health psychologist for the Eskenazi Health Palliative Care Program. Dr. Johns also serves as an associate professor of medicine at Indiana University School of Medicine. 

Related News

Regenstrief Research Scientist Wanzhu Tu, PhD

Parental liver disease death more than doubles risk of alcohol-associated hepatitis in next generation

In a groundbreaking study, research scientists from the Indiana University School of Medicine and Regenstrief Institute found that individuals

image of elderly woman discussing pill bottle with her doctor

American Geriatrics Society unveils updated alternatives to potentially harmful medications for older adults

Regenstrief researcher serves on expert panel providing clinicians, patients and families with credible, actionable alternatives The American Geriatrics Society

LOINC version 2.81 release

Arabic and Czech translations, more than 4,000 new concepts boost global interoperability in latest LOINC® release

Regenstrief Institute’s latest LOINC® content update on August 12, introduces two new linguistic variants: Arabic, for users in Jordan,

Regenstrief President and CEO Rachel Patzer, PhD, MPH.

Regenstrief CEO among national honorees for ground-breaking achievements in transplantation

SAN FRANCISCO – Regenstrief Institute President and Chief Executive Officer Rachel Patzer, PhD, MPH, is among a select group